Reglan and Bydureon drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Reglan (metoclopramide hydrochloride) and Bydureon (exenatide synthetic). Common drug interactions include injection site haemorrhage among females and abscess among males.
The phase IV clinical study analyzes what interactions people have when they take Reglan and Bydureon. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Reglan?
Reglan has active ingredients of metoclopramide hydrochloride. It is often used in gastroparesis. eHealthMe is studying from 29,455 Reglan users. Check the latest studies of Reglan.
What is Bydureon?
Bydureon has active ingredients of exenatide synthetic. It is often used in type 2 diabetes. eHealthMe is studying from 24,309 Bydureon users. Check the latest studies of Bydureon.
29 people who take Reglan and Bydureon together, and have interactions are studied.

What are the common drug interactions of Reglan and Bydureon, by gender? *:
female:
- Injection site haemorrhage (bleeding from injection site)
- Injection site pain
- Hypertension (high blood pressure)
- Hypotension (abnormally low blood pressure)
- Injection site extravasation (flow of (blood or lymph) from injection site)
- Arthralgia (joint pain)
- Chronic kidney disease
- Pain
- Peripheral swelling
- Retching (strong involuntary effort to vomit)
male:
- Abscess (pus)
- Cellulitis (infection under the skin)
- Rectal abscess (pus in rectum)
- Tooth abscess (pus formation in tooth)
- Urinary tract infection
- Vomiting
- Weight decreased
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Chronic kidney disease
- Constipation
What are the common drug interactions of Reglan and Bydureon, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Chronic kidney disease
- Circulatory collapse
- Nephrogenic anaemia (anaemia due to kidney disease)
- Renal failure (kidney dysfunction)
- Renal tubular necrosis (death of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
40-49:
- Anal abscess
- Perirectal abscess
- Tooth abscess (pus formation in tooth)
- Abscess (pus)
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Dyspnoea (difficult or laboured respiration)
- Genital abscess (build up of pus in genital)
- Groin abscess (pus in groin)
- Rectal abscess (pus in rectum)
50-59:
- Hypotension (abnormally low blood pressure)
- Injection site extravasation (flow of (blood or lymph) from injection site)
- Arthralgia (joint pain)
- Pain
- Peripheral swelling
- Retching (strong involuntary effort to vomit)
- Thyroid disorder (thyroid diseases)
- Weight decreased
- Hypertension (high blood pressure)
- Injection site haemorrhage (bleeding from injection site)
60+:
- Chronic kidney disease
- Injection site haemorrhage (bleeding from injection site)
- Blood glucose increased
- Death
- Dehydration (dryness resulting from the removal of water)
- Diarrhoea
- Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
- Fall
- Fear
- Hypermagnesaemia (an electrolyte disturbance in which there is an abnormally elevated level of magnesium in the blood)
What are the existing conditions these people have? *
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 27.59%
- High Blood Pressure: 7 people, 24.14%
- Weight Decreased: 5 people, 17.24%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 17.24%
- Hypotension (abnormally low blood pressure): 4 people, 13.79%
- Blood Pressure Abnormal: 4 people, 13.79%
- Pain: 3 people, 10.34%
- Glycosylated Haemoglobin: 3 people, 10.34%
- Diabetes: 3 people, 10.34%
- Abdominal Discomfort: 3 people, 10.34%
* Approximation only. Some reports may have incomplete information.
Do you take Reglan and Bydureon?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Reglan and Bydureon:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Reglan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Bydureon:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Reglan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bydureon and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on metoclopramide hydrochloride and exenatide synthetic (the active ingredients of Reglan and Bydureon, respectively), and Reglan and Bydureon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Zide and Bactrim - 2 seconds ago
- Peripheral Arterial Occlusive Disease and Thrombocytopenia Aggravated - 2 seconds ago
- Could Bumetanide cause Breast Pain? - 23 seconds ago
- How effective is Flexeril for Fibromyalgia? - a minute ago
- Could Vistaril cause Thrombocytopenia? - a minute ago
- Could Roxicet cause Sedation? - a minute ago
- Drug interactions of Robaxin and Glucotrol - a minute ago
- Could Vasotec cause Gynecomastia? - a minute ago
- Marinol vs. Mobic, side effect and effectiveness comparison - a minute ago
- Glaucoma and Renal Failure Aggravated - 2 minutes ago